Clinical utility of p16/Ki67 dual‐stain cytology for detection of cervical intraepithelial neoplasia grade two or worse in women with a transformation zone type 3: A cross‐sectional study-Reference-Cited by-同舟云学术

Clinical utility of p16/Ki67 dual‐stain cytology for detection of cervical intraepithelial neoplasia grade two or worse in women with a transformation zone type 3: A cross‐sectional study

Published:2022-06-22 Issue:2 Volume:130 Page:202-209
ISSN:1470-0328
Container-title:BJOG: An International Journal of Obstetrics & Gynaecology
language:en
Short-container-title:BJOG

Author:

Gustafson Line Winther¹²³^ORCID,Tranberg Mette¹,Christensen Pia Nørgaard⁴,Brøndum Rikke⁴,Wentzensen Nicolas⁵,Clarke Megan A.⁵,Andersen Berit¹²,Petersen Lone Kjeld⁶⁷,Bor Pinar²⁸,Hammer Anne²⁹^ORCID

Affiliation:

1. University Research Clinic for Cancer Screening, Department of Public Health Programmes Randers Regional Hospital Randers Denmark

2. Department of Clinical Medicine Aarhus University Aarhus Denmark

3. Department of Obstetrics and Gynaecology Aarhus University Hospital Aarhus Denmark

4. Department of Pathology Randers Regional Hospital Randers Denmark

5. Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics National Cancer Institute Rockville Maryland USA

6. Department of Obstetrics and Gynaecology Odense University Hospital and Open Patient Data Explorative Network Odense Denmark

7. Department of Clinical Research University of Southern Denmark Odense Denmark

8. Department of Obstetrics and Gynaecology Randers Regional Hospital Randers Denmark

9. Department of Obstetrics and Gynaecology NIDO Denmark, Gødstrup Hospital Herning Denmark

Funder

Dagmar Marshalls Fond

Roche Diagnostics

Publisher

Wiley

Subject

Obstetrics and Gynecology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1471-0528.17248

Reference38 articles.

1. Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study

2. Multiple Biopsies and Detection of Cervical Cancer Precursors at Colposcopy

3. Gynecology SSoOa.SFOG‐riktlinje av NVP för cervixcancerprevention. Updated 190330 [cited 2020 Oct 30]. Available from:https://www.sfog.se/media/336482/sfog‐riktlinje‐190330_revhs‐190413.pdf

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PCDHGB7 hypermethylation-based Cervical cancer Methylation (CerMe) detection for the triage of high-risk human papillomavirus-positive women: a prospective cohort study;BMC Medicine;2024-02-05

2. Validation of an on-chip p16ink4a/Ki-67 dual immunostaining cervical cytology system using microfluidic device technology;Scientific Reports;2023-10-10

3. Authors' reply;BJOG: An International Journal of Obstetrics & Gynaecology;2023-09-05

4. Beyond P16/Ki67 dual‐stain cytology: Exploring alternative biomarkers for diagnosing cervical cancer and its precursors;BJOG: An International Journal of Obstetrics & Gynaecology;2023-06-22

5. Risk of cervical intraepithelial neoplasia grade 2 or worse in women aged ≥ 69 referred to colposcopy due to an HPV-positive screening test;BMC Cancer;2023-05-05